MétaCan
Menu
Back to cohort
Record W4391002517 · doi:10.1016/j.kint.2023.11.018

Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today

2024· article· en· W4391002517 on OpenAlexfundno aff
Howard Trachtman, Hailey Desmond, Amanda Williams, Laura Mariani, Sean Eddy, Wenjun Ju, Laura Barisoni, Heather Ascani, Wendy R. Uhlmann, Cathie Spino, Lawrence B. Holzman, John R. Sedor, Crystal A. Gadegbeku, Lalita Subramanian, Chrysta Lienczewski, Tina Manieri, Scott J. Roberts, Debbie S. Gipson, Matthias Kretzler, Susan F. Massengill, Layla Lo, Katherine M. Dell, John O’Toole, Blair Martin, Ian Macumber, Silpa Sharma, Tarak Srivastava, Kelsey Markus, Christine B. Sethna, Suzanne Vento, Pietro A. Canetta, Opeyemi A. Olabisi, Rasheed Gbadegesin, Maurice A. Smith, Laurence Greenbaum, Chia-shi Wang, Emily Yun, Sharon G. Adler, Janine LaPage, Amatur Amarah, M. Itteera, Meredith A. Atkinson, Miahje Williams, John C. Lieske, Marie C. Hogan, Fernando C. Fervenza, David T. Selewski, Cheryl Alston, Kim Reidy, Michael D. Ross, Frederick J. Kaskel, P. Flynn, Laura Málaga-Diéguez, Olga Zhdanova, Laura Jane Pehrson, Melanie Miranda, Salem Almaani, Laci Roberts, Richard Lafayette, Shiktij Dave, Iris Lee, Shweta Shah, Sadaf Batla, Heather N. Reich, Michelle Hladunewich, Paul Ling, Martin Romano, Paul Brakeman, James Dylewski, Nathan Rogers, Ellen T. McCarthy, Catherine Creed, Alessia Fornoni, Miguel Bandes, Zubin J. Modi, Roxy Ni, Patrick H. Nachman, Michelle N. Rheault, A Kowalski, Nicolas Rauwolf, Vimal K. Derebail, Keisha L. Gibson, Anne Froment, Sara Kelley, Kevin Meyers, K. Kallem, Aliya Edwards, Samin K. Sharma, Elizabeth Roehm, Kamalanathan K. Sambandam, E. Sherwood Brown, Jamie Hellewege, A. Jefferson, Sangeeta Hingorani, Katherine R. Tuttle, L. Manahan, Emily Pao, Kelli Kuykendall, Jen Jar Lin, Vikas R. Dharnidharka, Brenda W. Gillespie, Eloise Salmon, T. Mainieri, Gabrielle Alter, Michael Arbit, Damian Fermin, Maria Larkina, Rebecca Scherr, Jonathan P. Troost, Yan Zhai, Colleen Kincaid, Shengqian Li, Shannon Li, Matthew G. Sampson, Jarcy Zee, Carmen Ávila-Casado, Serena M. Bagnasco, Lihong Bu, Shelley Caltharp, Clarissa A. Cassol, Dawit Demeke, Jared Hassler, Leal Herlitz, Stephen M. Hewitt, Jeff Hodgin, Danni Holanda, Neeraja Kambham, Kevin V. Lemley, Nidia Messias, Alexei Mikhailov, Vanessa Moreno, Behzad Najafian, Matthew Palmer, Avi Z. Rosenberg, Virginie Royal, Miroslav Sekulik, David B. Thomas, Ming‐Shiou Wu, M Yamashita, Hong Yin, Yiqin Zuo . Cochairs, Cynthia C. Nast

Bibliographic record

VenueKidney International · 2024
Typearticle
Languageen
FieldMedicine
TopicRenal Diseases and Glomerulopathies
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesNational Institute of Neurological Disorders and StrokeNational Institute of Allergy and Infectious DiseasesGenentechCenters for Disease Control and PreventionAstellas PharmaEuropean CommissionAngionMaze TherapeuticsHalpin FoundationRare Diseases Clinical Research NetworkImmune Tolerance NetworkNational Institutes of HealthNateraRegeneron PharmaceuticalsJanssen PharmaceuticalsUniversity of WashingtonNephcure FoundationChildren's Mercy HospitalJohns Hopkins UniversityUniversity of North Carolina at Chapel HillAlport Syndrome FoundationWashington University in St. LouisAnschutz Medical Campus, University of ColoradoUniversity of South CarolinaUniversity of MichiganUniversity of MinnesotaNational Cancer InstituteGilead SciencesWake Forest UniversityOhio State UniversityNovo NordiskUniversity of PennsylvaniaAmerican Society of NephrologyTexas Children's HospitalNational Institute of Diabetes and Digestive and Kidney DiseasesTemple UniversitySanofiEli Lilly and CompanyAstraZenecaYork UniversityModernaUniversity of MiamiCleveland ClinicEmory University
KeywordsClinical trialMedicineNephrologyNephrotic syndromeIntensive care medicineDiseaseInternal medicineBioinformaticsBiology

Abstract

fetched live from OpenAlex

Glomerular diseases are classified using a descriptive taxonomy that is not reflective of the heterogeneous underlying molecular drivers. This limits not only diagnostic and therapeutic patient management, but also impacts clinical trials evaluating targeted interventions. The Nephrotic Syndrome Study Network (NEPTUNE) is poised to address these challenges. The study has enrolled >850 pediatric and adult patients with proteinuric glomerular diseases who have contributed to deep clinical, histologic, genetic, and molecular profiles linked to long-term outcomes. The NEPTUNE Knowledge Network, comprising combined, multiscalar data sets, captures each participant's molecular disease processes at the time of kidney biopsy. In this editorial, we describe the design and implementation of NEPTUNE Match, which bridges a basic science discovery pipeline with targeted clinical trials. Noninvasive biomarkers have been developed for real-time pathway analyses. A Molecular Nephrology Board reviews the pathway maps together with clinical, laboratory, and histopathologic data assembled for each patient to compile a Match report that estimates the fit between the specific molecular disease pathway(s) identified in an individual patient and proposed clinical trials. The NEPTUNE Match report is communicated using established protocols to the patient and the attending nephrologist for use in their selection of available clinical trials. NEPTUNE Match represents the first application of precision medicine in nephrology with the aim of developing targeted therapies and providing the right medication for each patient with primary glomerular disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.211
metaresearch head score (Gemma)0.235
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.211
Threshold uncertainty score0.973

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2110.235
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0030.002
Science and technology studies0.0030.005
Scholarly communication0.0060.004
Open science0.0030.004
Research integrity0.0060.010
Insufficient payload (model declined to judge)0.0160.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.268
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations24
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueKidney InternationalSame topicRenal Diseases and GlomerulopathiesFrench-language works237,207